For decades, medicine handed Filipinos a familiar script: watch your cholesterol, exercise, and your heart will follow. Yet more than 130,000 die each year from cardiovascular disease — many of them dutiful followers of that very script. Research presented at the European Society of Cardiology Congress in Madrid in 2025 now suggests that chronic inflammation, long overlooked and largely symptomless, may be a more powerful harbinger of heart attacks and strokes than cholesterol ever was, inviting a quiet but consequential reckoning with what we thought we understood about the human heart.
Inflammation, not cholesterol alone, emerges as hidden heart disease driver in Philippines
Over 130,000 Filipinos die annually from cardiovascular diseases, with increasing cases among those appearing to maintain healthy lifestyles.
Someone with normal cholesterol can still be at serious risk
Mark
So if someone has normal cholesterol and exercises regularly, they're still at risk for a heart attack?
Mimi
According to the research presented in Madrid, yes—if they have high inflammation. That's the key finding. Inflammation appears to be driving cardiovascular events independently of cholesterol levels.
Luke
But how is inflammation measured? Is this something doctors are routinely testing for in the Philippines right now?
Mimi
That's the gap. Inflammation markers exist—things like C-reactive protein—but they're not part of standard screening the way cholesterol is.
Mark
So 130,000 deaths a year, and we don't even know how many of those people had undetected inflammation?
Mimi
Exactly. The research suggests it could be a significant portion, especially among people who thought they were low-risk because their cholesterol was fine.
Luke
The study was presented at a cardiology congress, but do we know if it's being implemented in Philippine hospitals yet? Or is this still mostly awareness-raising?
Mimi
The reporting doesn't specify implementation. It's framed as a call for awareness—Dr. Buena-Bobis says many at-risk Filipinos are still unaware of inflammation's role.
Mark
What would change if doctors started screening for inflammation routinely?
Mimi
People could identify risk earlier, potentially before a heart attack or stroke. And treatment options might shift—anti-inflammatory approaches rather than just cholesterol management.
Luke
Is there evidence that treating inflammation actually prevents those events, or is this still correlational?
Mimi
The source doesn't detail treatment outcomes—just that inflammation is a predictor. That's an important distinction.
Mark
So the story is really about a gap in knowledge, not yet about a solution.
Mimi
Right. It's the beginning of a conversation, not the end of one.
The Pulse
- Over 130,000 Filipinos die from heart disease annually, and a troubling share of them had normal cholesterol and seemingly healthy habits — the standard safeguards simply did not hold.
- Researchers from the Karolinska Institute, in collaboration with Novo Nordisk, presented data at the 2025 ESC Congress showing that elevated inflammation markers independently predicted heart attacks, strokes, and death — even when cholesterol levels appeared reassuring.
- Chronic inflammation is particularly insidious because it produces no obvious symptoms, meaning millions of Filipinos may carry serious cardiovascular risk without any signal that something is wrong.
- Dr. Neslie Buena-Bobis of Novo Nordisk Philippines has identified a critical awareness gap: the traditional markers Filipinos are taught to monitor are not sufficient, and inflammation remains largely outside the public conversation on heart health.
- The path forward demands more than new tests — it requires a systemic shift in how physicians counsel patients and how preventive care campaigns are designed, moving inflammation from the margins to the center of cardiovascular risk.
For decades, medicine handed Filipinos a familiar script: watch your cholesterol, exercise, and your heart will follow. Yet more than 130,000 die each year from cardiovascular disease — many of them dutiful followers of that very script. Research presented at the European Society of Cardiology Congress in Madrid in 2025 now suggests that chronic inflammation, long overlooked and largely symptomless, may be a more powerful harbinger of heart attacks and strokes than cholesterol ever was, inviting a quiet but consequential reckoning with what we thought we understood about the human heart.
Every year, more than 130,000 Filipinos die from cardiovascular disease — and what makes the toll especially haunting is how many of those lives belonged to people who followed the rules. Normal cholesterol. Regular exercise. No smoking. The standard medical playbook, followed faithfully, and still their hearts gave out.
At the European Society of Cardiology Congress in Madrid in 2025, researchers from the Karolinska Institute and Novo Nordisk offered a possible explanation for this painful paradox. Their findings suggest that chronic inflammation circulating through the body may be a stronger predictor of heart attacks and strokes than cholesterol levels — and that elevated inflammation independently raises risk even when lipid numbers look perfectly fine.
For years, cholesterol has occupied the center of the cardiovascular conversation. Patients have been counseled on statins, diet, and lipid panels. These interventions remain meaningful. But the new research reveals they may be telling only part of the story. Chronic inflammation, unlike high cholesterol, produces no obvious symptoms — it moves silently, and most people have no reason to suspect it is there.
Dr. Neslie Buena-Bobis, who leads clinical and medical affairs for Novo Nordisk Philippines, put the challenge directly: many Filipinos at risk remain unaware that inflammation is a central factor in their vulnerability. The markers they know to watch are not enough.
The data from Madrid is drawn from real-world evidence, not theoretical models, and its message is unambiguous. What remains uncertain is how swiftly it reshapes clinical practice in the Philippines — whether physicians will begin screening for inflammation alongside cholesterol, and whether public health campaigns will expand their vocabulary to match what the science is now saying.
Every year, more than 130,000 Filipinos die from cardiovascular disease. The number keeps climbing. What makes this particularly unsettling is that many of these deaths occur in people who did everything right—they kept their cholesterol in check, exercised regularly, never smoked. They followed the playbook that medicine has been handing out for decades. And yet their hearts still failed them.
This gap between what we thought we knew and what is actually happening has begun to shift the conversation among cardiologists. At the European Society of Cardiology Congress held in Madrid in 2025, researchers from the Karolinska Institute, working with pharmaceutical company Novo Nordisk, presented findings that reframe how we should think about heart disease risk. The data suggests that inflammation circulating through the body may be a more powerful predictor of heart attacks and strokes than cholesterol levels themselves. People with high inflammation markers face significantly elevated risk, even if their cholesterol numbers look reassuring.
The implications are substantial. For years, the medical establishment has focused heavily on cholesterol as the primary villain in cardiovascular disease. Patients have been counseled to watch their numbers, take statins, modify their diets. These interventions matter. But the new research indicates they may not be capturing the full picture. Someone can have normal cholesterol and still be at serious risk if their body is in a state of chronic inflammation—a condition that often goes undetected because it produces no obvious symptoms.
Dr. Neslie Buena-Bobis, who directs clinical and medical affairs for Novo Nordisk Philippines, framed the challenge plainly: many Filipinos at risk for heart disease remain unaware that inflammation plays a central role in their vulnerability. The traditional markers—the ones people know to monitor—are not sufficient warning systems. This represents a fundamental gap in how cardiovascular risk is currently understood and communicated in the country.
The research presented in Madrid drew on real-world data, not just laboratory models or theoretical projections. The findings showed that elevated inflammation levels independently predicted heart attacks, strokes, and death, regardless of whether cholesterol was elevated. This distinction matters enormously for how patients should approach their health. Someone with normal cholesterol who experiences chronic inflammation is not actually in the clear, even if their doctor has given them reassurance based on lipid panels alone.
What remains to be seen is how quickly this knowledge translates into clinical practice in the Philippines. Screening for inflammation markers requires different tests than cholesterol screening. It requires awareness among both physicians and patients that the risk exists. It requires a shift in how preventive care is framed—moving beyond the familiar cholesterol conversation toward a more complex understanding of what actually triggers cardiovascular events. The data is clear. The question now is whether the healthcare system, and the public it serves, will adjust accordingly.
Notable Quotes
Heart disease continues to be the number one killer in the country but many at-risk Filipinos are still unaware of the role inflammation plays— Dr. Neslie Buena-Bobis, Novo Nordisk Philippines
Want the full story?
Read the original at The Manila Times ↗
Politics & Governance